Viorica Chelban,Matthew P Wilson,Jodi Warman Chardon,Jana Vandrovcova,M Natalia Zanetti,Eleni Zamba-Papanicolaou,Stephanie Efthymiou,Simon Pope,Maria R Conte,Giancarlo Abis,Yo-Tsen Liu,Eloise Tribollet,Nourelhoda A Haridy,Juan A Botía,Mina Ryten,Paschalis Nicolaou,Anna Minaidou,Kyproula Christodoulou,Kristin D Kernohan,Alison Eaton,Matthew Osmond,Yoko Ito,Pierre Bourque,James E C Jepson,Oscar Bello,Fion Bremner,Carla Cordivari,Mary M Reilly,Martha Foiani,Amanda Heslegrave,Henrik Zetterberg,Simon J R Heales,Nicholas W Wood,James E Rothman,Kym M Boycott,Philippa B Mills,Peter T Clayton,Henry Houlden,Care4Rare Canada Consortium and the SYNaPS Study Group,Yamna Kriouile,Mohamed El Khorassani,Mhammed Aguennouz,Stanislav Groppa,Blagovesta Marinova Karashova,Lionel Van Maldergem,Wolfgang Nachbauer,Sylvia Boesch,Larissa Arning,Dagmar Timmann,Bru Cormand,Belen Pérez-Dueñas,Gabriella Di Rosa,Jatinder S Goraya,Tipu Sultan,Jun Mine,Daniela Avdjieva,Hadil Kathom,Radka Tincheva,Selina Banu,Mercedes Pineda-Marfa,Pierangelo Veggiotti,Michel D Ferrari,Arn M J M van den Maagdenberg,Alberto Verrotti,Giangluigi Marseglia,Salvatore Savasta,Mayte García-Silva,Alfons Macaya Ruiz,Barbara Garavaglia,Eugenia Borgione,Simona Portaro,Benigno Monteagudo Sanchez,Richard Boles,Savvas Papacostas,Michail Vikelis,James Rothman,Paola Giunti,Vincenzo Salpietro,Emer Oconnor,Dimitri Kullmann,Rauan Kaiyrzhanov,Roisin Sullivan,Alaa Matooq Khan,Wai Yan Yau,Isabel Hostettler,Eleni Zamba Papanicolaou,Efthymios Dardiotis,Shazia Maqbool,Shahnaz Ibrahim,Salman Kirmani,Nuzhat Noureen Rana,Osama Atawneh,Shen-Yang Lim,Farooq Shaikh,George Koutsis,Marianthi Breza,Salvatore Mangano,Carmela Scuderi,Giovanna Morello,Tanya Stojkovic,Erin Torti,Massimi Zollo,Gali Heimer,Yves A Dauvilliers,Pasquale Striano,Issam Al-Khawaja,Fuad Al-Mutairi,Fowzan S Alkuraya,Hamed Sherifa,Mie Rizig,Njideka U Okubadejo,Oluwadamilola O Ojo,Olajumoke O Oshinaike,Kolawole Wahab,Abiodun H Bello,Sanni Abubakar,Yahaya Obiabo,Ernest Nwazor,Oluchi Ekenze,Uduak Williams,Alagoma Iyagba,Lolade Taiwo,Morenikeji Komolafe,Olapeju Oguntunde,Sofya Pchelina,Konstantin Senkevich,Nourelhoda Haridy,Chingiz Shashkin,Nazira Zharkynbekova,Kairgali Koneyev,Ganieva Manizha,Maksud Isrofilov,Ulviyya Guliyeva,Kamran Salayev,Samson Khachatryan,Salvatore Rossi,Gabriella Silvestri,Thomas Bourinaris,Georgia Xiromerisiou,Liana Fidani,Cleanthe Spanaki,Arianna Tucci

Abstract:Objective: To identify disease-causing variants in autosomal recessive axonal polyneuropathy with optic atrophy and provide targeted replacement therapy. Methods: We performed genome-wide sequencing, homozygosity mapping, and segregation analysis for novel disease-causing gene discovery. We used circular dichroism to show secondary structure changes and isothermal titration calorimetry to investigate the impact of variants on adenosine triphosphate (ATP) binding. Pathogenicity was further supported by enzymatic assays and mass spectroscopy on recombinant protein, patient-derived fibroblasts, plasma, and erythrocytes. Response to supplementation was measured with clinical validated rating scales, electrophysiology, and biochemical quantification. Results: We identified biallelic mutations in PDXK in 5 individuals from 2 unrelated families with primary axonal polyneuropathy and optic atrophy. The natural history of this disorder suggests that untreated, affected individuals become wheelchair-bound and blind. We identified conformational rearrangement in the mutant enzyme around the ATP-binding pocket. Low PDXK ATP binding resulted in decreased erythrocyte PDXK activity and low pyridoxal 5'-phosphate (PLP) concentrations. We rescued the clinical and biochemical profile with PLP supplementation in 1 family, improvement in power, pain, and fatigue contributing to patients regaining their ability to walk independently during the first year of PLP normalization. Interpretation: We show that mutations in PDXK cause autosomal recessive axonal peripheral polyneuropathy leading to disease via reduced PDXK enzymatic activity and low PLP. We show that the biochemical profile can be rescued with PLP supplementation associated with clinical improvement. As B6 is a cofactor in diverse essential biological pathways, our findings may have direct implications for neuropathies of unknown etiology characterized by reduced PLP levels. ANN NEUROL 2019;86:225-240.

Novel PNKP Mutations Causing Defective DNA Strand Break Repair and PARP1 Hyperactivity in MCSZ.

Novel PNKP mutations associated with reduced DNA single-strand break repair and severe microcephaly, seizures, and developmental delay

Pathological mutations in PNKP trigger defects in DNA single-strand break repair but not DNA double-strand break repair

Polynucleotide kinase–phosphatase enables neurogenesis via multiple DNA repair pathways to maintain genome stability

PIK3CA-associated developmental disorders exhibit distinct classes of mutations with variable expression and tissue distribution

Parp1 hyperactivity couples DNA breaks to aberrant neuronal calcium signalling and lethal seizures

The role of the mammalian DNA end-processing enzyme polynucleotide kinase 3'-phosphatase in spinocerebellar ataxia type 3 pathogenesis

Novel compound heterozygous mutations in the PANK2 gene in a Chinese patient with atypical pantothenate kinase-associated neurodegeneration.

PNKP mutation in a child: is there a firm line between MCSZ and AOA4 phenotype?

Inactivation of PNKP by mutant ATXN3 triggers apoptosis by activating the DNA damage-response pathway in SCA3

Psychomotor development and attention problems caused by a splicing variant of CNKSR2

Efficient Cnv Breakpoint Analysis Reveals Unexpected Structural Complexity and Correlation of Dosage-Sensitive Genes with Clinical Severity in Genomic Disorders

Complex Mosaicism of Two Distinct Mutations in a Female Patient with KCNA2-Related Encephalopathy: A Case Report.

Identification of Oliver-McFarlane syndrome caused by novel compound heterozygous variants of PNPLA6

Germline recessive mutations in PI4KA are associated with perisylvian polymicrogyria, cerebellar hypoplasia and arthrogryposis

Plural molecular and cellular mechanisms of pore domain KCNQ2 encephalopathy

Mutations Disrupting Neuritogenesis Genes Confer Risk for Cerebral Palsy.

PDXK mutations cause polyneuropathy responsive to pyridoxal 5'-phosphate supplementation

iPSC-Derived Neurons from Patients with POLG Mutations Exhibit Decreased Mitochondrial Content and Dendrite Simplification

Mutations in Spliceosomal Genes PPIL1 and PRP17 Cause Neurodegenerative Pontocerebellar Hypoplasia with Microcephaly.

Unilateral Focal Palmoplantar Keratoderma Associated with a Postzygotic Variant in PIK3CA and Activation of the PI3K/AKT/mTOR Pathway.